Genmab



Ebit Veränderung Datum
Agios Pharmaceuticals USD -125037000 22.23M 2024-12
Almirall EUR 50.09M 65.59M 2024-06
Amarin USD -25168000 24.64M 2024-09
Amgen USD 4.03B 11M 2024-12
argenx SE USD 14.19M 28.62M 2024-09
AstraZeneca USD 4.2B 119M 2024-12
Bayer EUR 855M 588M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Demant DKK 2.34B 144M 2024-12
Exelixis USD 163.46M 27.38M 2024-12
Fresenius Medical Care EUR 489M 15M 2024-12
Galapagos EUR -62721000 8.42M 2024-12
Genmab DKK 2.16B 58M 2024-12
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
GN Store Nord DKK 601M 142M 2024-12
GRIFOLS EUR 269.49M 73.1M 2024-06
Hikma Pharmaceutical USD 402M 96M 2024-06
Insmed USD -245214000 31.78M 2024-12
Lonza CHF 727M 193M 2024-12
Merck EUR 868M 229M 2024-12
Novartis USD 4.86B 286M 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.08B 1.69B 2024-12
UCB EUR 334M 163M 2024-06



Genmab - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.